Bivalirudin Versus Enoxaparin in Critically Ill COVID-19 Patients
Conditions: Acute Respiratory Failure; SARS CoV 2 Infection; Anticoagulants Interventions: Drug: Enoxaparin Sodium; Drug: Bivalirudin Sponsor: University Magna Graecia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2022 Category: Research Source Type: clinical trials
Anticoagulation in critically ill patients on mechanical ventilation suffering from COVID-19 disease, The ANTI-CO trial: A structured summary of a study protocol for a randomised controlled trial
AbstractObjectivesTo assess the effect of anticoagulation with bivalirudin administered intravenously on gas-exchange in patients with COVID-19 and respiratory failure using invasive mechanical ventilation.Trial designThis is a single centre parallel group, superiority, randomized (1:1 allocation ratio) controlled trial.ParticipantsAll patients admitted to the Hamad Medical Corporation -ICU in Qatar for COVID-19 associated respiratory distress and in need of mechanical ventilation are screened for eligibility.Inclusion criteria: all adult patients admitted to the ICU who test positive for COVID-19 by PCR-test and in need f...
Source: Trials - September 6, 2020 Category: Research Source Type: clinical trials
Efficacy and Safety of Bivalirudin Versus Heparin During Coil Embolization in Patients With Ruptured Intracranial Aneurysms
Condition: Subarachnoid Hemorrhage, Aneurysmal Interventions: Drug: Bivalirudin 250 MG Injection; Drug: Heparin Sponsors: Changhai Hospital; The First Affiliated Hospital of Zhengzhou University; Zhejiang University; Wuhan University; Qilu Hospital of Shandong University; The First People's Hospital of Changzhou Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2020 Category: Research Source Type: clinical trials
